Discussion of the evaluation of the treatment of Partial Rupture of the Supraspinatus Tendon with the Needling technique associated with Platelet Rich Plasma

Not Applicable

• Conditions: Partial Rupture of the Rotator Cuff; A02.880

• Registration Number: RBR-7rk26hj
• Lead Sponsor: Centro de Hematologia e Hemoterapia - HEMOCENTRO UNICAMP

Brief Summary

The aim of this study was to compare the effects of barbotage of the supraspinatus tendon (ST) partial rupture with or without Platelet Rich Plasma (PRP) using the Western Ontario Rotator Cuff Index score, and ultrasound (US) images, at 6 weeks and 6 months after treatment. Patients showed clinical improvement in both groups, and no significant difference in the score at 6 weeks was found. However, at 6 months a significant improvement was observed in the PRP group (p=0,019). Supraspinatus Tendon rupture decreased in both groups after treatment, and there was a significant enhancement at 6 weeks and 6 months in the PRP group. In conclusion, US guided barbotage technique associated with PRP or saline solution are effective treatments for clinical improvement and decrease in the size of the partial ST tear, with better results with PRP in clinical improvement at 6 months. The association of PRP with barbotage is superior in reducing the size of the ST tear at 6 weeks and 6 months, reaching complete healing in 79,3% of the tears.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-03-03
• Study Start: 2023-05-29
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients of both sexes, aged over 25 years, with partial rupture of the supraspinatus less than or equal to 1 cm in the longitudinal axis evaluated by ultrasound.

Exclusion Criteria

Patients who underwent any ultrasound-guided needling procedure in the affected tendon, use of infiltration with corticosteroids in the affected shoulder in the last 6 months, presence of another pathology of the shoulder to be treated (fracture or arthritis of rheumatic origin), cervical spine radiculopathy, pregnancy, neoplasm, severe liver disease or nephropathy, autoimmune, inflammatory or infectious diseases, acute or chronic, hypersensitivity to lidocaine, use of anti-inflammatory drugs or corticosteroids in any form before 6 weeks of application of platelet-rich plasma

Study & Design

• Study Type: Intervention
• Study Design: Not specified